|
GB8918616D0
(en)
|
1989-08-15 |
1989-09-27 |
Univ Glasgow |
Herpes simplex virus type 1 mutant
|
|
US5849572A
(en)
|
1990-10-10 |
1998-12-15 |
Regents Of The University Of Michigan |
HSV-1 vector containing a lat promoter
|
|
US5804413A
(en)
|
1992-07-31 |
1998-09-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
|
EP1637608B1
(en)
|
1993-10-25 |
2009-07-22 |
CANJI, Inc. |
Recombinant adenoviral vector and methods of use
|
|
GB9415319D0
(en)
|
1994-07-29 |
1994-09-21 |
Medical Res Council |
HSV viral vector
|
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
|
US5801030A
(en)
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
|
US5837511A
(en)
|
1995-10-02 |
1998-11-17 |
Cornell Research Foundation, Inc. |
Non-group C adenoviral vectors
|
|
US5849561A
(en)
|
1997-05-22 |
1998-12-15 |
Cornell Research Foundation, Inc. |
Method for the production of non-group C adenoviral vectors
|
|
AU8605598A
(en)
|
1997-07-31 |
1999-02-22 |
University Of Pittsburgh |
Targeted hsv vectors
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
US6562943B1
(en)
*
|
1999-04-21 |
2003-05-13 |
Zycos, Inc. |
Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
|
|
NZ522840A
(en)
|
2000-06-01 |
2004-12-24 |
Univ North Carolina |
A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together
|
|
US7122181B2
(en)
|
2000-12-19 |
2006-10-17 |
Research Development Foundation |
Lentiviral vector-mediated gene transfer and uses thereof
|
|
AU2002303330B2
(en)
|
2001-05-31 |
2008-07-24 |
Novartis Vaccines And Diagnostics, Inc. |
Chimeric alphavirus replicon particles
|
|
US20070129307A1
(en)
|
2001-06-22 |
2007-06-07 |
The University Of British Columbia |
Insulin epitopes for the treatment of type 1 diabetes
|
|
EP1412493B1
(en)
|
2001-08-02 |
2011-10-05 |
Institut Clayton De La Recherche |
Methods and compositions relating to improved lentiviral vector production systems
|
|
WO2003023026A1
(en)
|
2001-09-06 |
2003-03-20 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
EP1438075A4
(en)
|
2001-10-02 |
2006-04-19 |
Inst Clayton De La Rech |
METHOD AND COMPOSITIONS ASSOCIATED WITH LENTIVIRAL VECTORS WITH LIMITED EXPRESSION AND ITS APPLICATIONS
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
DE60333487D1
(de)
|
2002-12-13 |
2010-09-02 |
Genetix Pharmaceuticals Inc |
Therapeutische retrovirus-vektoren für gentherapie
|
|
WO2004075861A2
(en)
|
2003-02-26 |
2004-09-10 |
Children's Hospital, Inc. |
Recombinant adeno-associated virus production
|
|
US7186699B2
(en)
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
US20050100890A1
(en)
|
2003-10-15 |
2005-05-12 |
Davidson Beverly L. |
Methods for producing and using in vivo pseudotyped retroviruses
|
|
AU2006214278C1
(en)
|
2005-02-16 |
2012-07-19 |
Miltenyi Biotec Technology, Inc. |
Lentiviral vectors and their use
|
|
CA2609276A1
(en)
|
2005-05-23 |
2006-11-30 |
De-Chu C. Tang |
Rapid production of adenovirus-free recombinant adenovirus vectors
|
|
FI20050814A0
(fi)
|
2005-08-11 |
2005-08-11 |
Procollagen Oy |
Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
|
|
DE602006019916D1
(de)
|
2005-12-12 |
2011-03-10 |
Canji Inc |
Adenovirale expressionsvektoren mit einer expressionskassette im e1-bereich und einer inaktivierten e2b-polymerase
|
|
GB0526211D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Viral vectors
|
|
US20080026485A1
(en)
|
2006-04-18 |
2008-01-31 |
Wolfgang Hueber |
Antibody profiling for determination of patient responsiveness
|
|
ES2465996T3
(es)
|
2006-05-25 |
2014-06-09 |
Sangamo Biosciences, Inc. |
Métodos y composiciones para la inactivación genética
|
|
KR101520507B1
(ko)
|
2006-12-14 |
2015-05-29 |
다우 아그로사이언시즈 엘엘씨 |
최적화된 비-정규 아연 손가락 단백질
|
|
US20100047256A1
(en)
|
2007-01-25 |
2010-02-25 |
Imperial Innovations Limited |
Methods
|
|
ES2708856T3
(es)
|
2007-08-03 |
2019-04-11 |
Pasteur Institut |
Vectores de transferencia de gen lentivírico y sus aplicaciones medicinales
|
|
EP2215223B1
(en)
|
2007-10-31 |
2013-05-01 |
Precision Biosciences, Inc. |
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
|
|
JP2011503232A
(ja)
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
|
EP2215252A4
(en)
|
2007-12-07 |
2011-01-26 |
Prec Biosciences Inc |
RATIONAL-DESIGNED MEGANUCLEASES WITH DETECTION SEQUENCES FROM DNASE-HYPERSENSITIVE REGIONS OF THE HUMAN GENOME
|
|
WO2009114321A2
(en)
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
|
EP2276833A4
(en)
|
2008-03-21 |
2011-06-29 |
Brigham & Womens Hospital |
MODULATION OF THE IMMUNE RESPONSE
|
|
WO2009146179A1
(en)
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
|
EP2342321B1
(en)
|
2008-09-17 |
2018-04-11 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
|
US20100216804A1
(en)
*
|
2008-12-15 |
2010-08-26 |
Zale Stephen E |
Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents
|
|
US8679837B2
(en)
|
2009-04-02 |
2014-03-25 |
University Of Florida Research Foundation, Inc. |
Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors
|
|
WO2011036640A2
(en)
|
2009-09-24 |
2011-03-31 |
Cellectis |
Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
|
|
US20120283318A1
(en)
|
2009-10-05 |
2012-11-08 |
Mei Ya-Fang |
Replicating viral vectors for gene therapy
|
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
|
HUE041436T2
(hu)
|
2009-12-10 |
2019-05-28 |
Univ Minnesota |
Tal-effektor-közvetített DNS-módosítás
|
|
EP2534163B1
(en)
|
2010-02-09 |
2015-11-04 |
Sangamo BioSciences, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
ES2685611T3
(es)
|
2011-02-14 |
2018-10-10 |
The Children's Hospital Of Philadelphia |
Vector VAA8 mejorado con una actividad funcional aumentada y métodos de utilización del mismo
|
|
WO2012145509A2
(en)
|
2011-04-19 |
2012-10-26 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors, and viruses
|
|
KR20140041505A
(ko)
*
|
2011-04-29 |
2014-04-04 |
셀렉타 바이오사이언시즈, 인크. |
조절 b 세포 유도를 위한 관용원성 합성 나노운반체
|
|
KR101873447B1
(ko)
|
2011-06-22 |
2018-07-03 |
삼성디스플레이 주식회사 |
신규한 화합물 및 이를 포함한 유기발광 소자
|
|
RU2650811C2
(ru)
|
2012-02-24 |
2018-04-17 |
Фред Хатчинсон Кэнсер Рисерч Сентер |
Композиции и способы лечения гемоглобинопатии
|
|
EP2638896A1
(en)
|
2012-03-14 |
2013-09-18 |
Bioneer A/S |
Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood
|
|
EP3663395B1
(en)
|
2012-03-26 |
2024-07-31 |
The United States of America, as Represented by The Secretary, Department of Health and Human Services Office of Technology, Transfer, |
Delivery of packaged rna to mammalian cells
|
|
AU2013249202B2
(en)
|
2012-04-18 |
2018-08-09 |
The Children's Hospital Of Philadelphia |
Composition and methods for highly efficient gene transfer using AAV capsid variants
|
|
US9738879B2
(en)
|
2012-04-27 |
2017-08-22 |
Duke University |
Genetic correction of mutated genes
|
|
JP2015529466A
(ja)
|
2012-09-14 |
2015-10-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
鎌状赤血球症の幹細胞遺伝子治療のためのレンチウイルスベクター
|
|
US9181535B2
(en)
|
2012-09-24 |
2015-11-10 |
The Chinese University Of Hong Kong |
Transcription activator-like effector nucleases (TALENs)
|
|
US9624510B2
(en)
|
2013-03-01 |
2017-04-18 |
The Wistar Institute |
Adenoviral vectors comprising partial deletions of E3
|
|
WO2014141244A1
(en)
|
2013-03-12 |
2014-09-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Synthetic peptides for the treatment of autoimmune diseases
|
|
BR112015026019A2
(pt)
|
2013-04-11 |
2017-07-25 |
Brigham & Womens Hospital Inc |
métodos e composições de tratamento de doenças autoimunes
|
|
US11414695B2
(en)
|
2013-05-29 |
2022-08-16 |
Agilent Technologies, Inc. |
Nucleic acid enrichment using Cas9
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
KR20160089528A
(ko)
|
2013-12-12 |
2016-07-27 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
신경퇴행성 질환의 치료
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
US20160060358A1
(en)
*
|
2014-08-28 |
2016-03-03 |
California Institute Of Technology |
Induction of antigen-specific tolerance
|
|
EP3188749A4
(en)
*
|
2014-09-03 |
2018-06-13 |
Moderna Therapeutics, Inc. |
Tolerogenic compositions and methods
|
|
CN107106543A
(zh)
|
2014-11-12 |
2017-08-29 |
布里格姆妇女医院 |
自身免疫性疾病中的褪黑激素
|
|
CA2980730A1
(en)
*
|
2015-03-23 |
2016-09-29 |
The Brigham And Women's Hospital, Inc. |
Tolerogenic nanoparticles for treating diabetes mellitus
|
|
GB201506112D0
(en)
|
2015-04-10 |
2015-05-27 |
Midatech Ltd And Inst Nationale De La Sant� Et De Al Rech Medicale And University College Car |
Nanoparticle-based antigen specific immunotherapy
|
|
WO2016168670A2
(en)
|
2015-04-16 |
2016-10-20 |
Longevica Therapeutics Inc. |
Methods for extending lifespan and methods of screening known pharmacological agents for new uses
|
|
EP3095440B1
(en)
*
|
2015-05-19 |
2020-01-15 |
PLS-Design GmbH |
Antigen-specific immunotherapy using tolerizing liposomes
|
|
US20170121683A1
(en)
*
|
2015-11-03 |
2017-05-04 |
Regents Of The University Of Minnesota |
Aryl hydrocarbon receptor disruption and enhancement
|
|
EP3713937A2
(en)
|
2017-11-20 |
2020-09-30 |
Ariagen, Inc. |
Indole compounds as aryl hydrocarbon receptor (ahr) modulators
|
|
JP2021515037A
(ja)
|
2018-02-26 |
2021-06-17 |
アントルクス，インコーポレーテッド |
寛容原性リポソーム及びその使用方法
|
|
US20230054194A1
(en)
|
2018-11-19 |
2023-02-23 |
Ariagen, Inc. |
Methods of Treating Cancer
|